Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

152 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prediction of metastatic pheochromocytoma and paraganglioma: a machine learning modelling study using data from a cross-sectional cohort.
Pamporaki C, Berends AMA, Filippatos A, Prodanov T, Meuter L, Prejbisz A, Beuschlein F, Fassnacht M, Timmers HJLM, Nölting S, Abhyankar K, Constantinescu G, Kunath C, de Haas RJ, Wang K, Remde H, Bornstein SR, Januszewicz A, Robledo M, Lenders JWM, Kerstens MN, Pacak K, Eisenhofer G. Pamporaki C, et al. Among authors: nolting s. Lancet Digit Health. 2023 Sep;5(9):e551-e559. doi: 10.1016/S2589-7500(23)00094-8. Epub 2023 Jul 18. Lancet Digit Health. 2023. PMID: 37474439 Free article.
The selective PI3Kα inhibitor BYL719 as a novel therapeutic option for neuroendocrine tumors: Results from multiple cell line models.
Nölting S, Rentsch J, Freitag H, Detjen K, Briest F, Möbs M, Weissmann V, Siegmund B, Auernhammer CJ, Aristizabal Prada ET, Lauseker M, Grossman A, Exner S, Fischer C, Grötzinger C, Schrader J, Grabowski P; GERMAN NET-Z study group. Nölting S, et al. PLoS One. 2017 Aug 11;12(8):e0182852. doi: 10.1371/journal.pone.0182852. eCollection 2017. PLoS One. 2017. PMID: 28800359 Free PMC article.
GSK3α/β: A Novel Therapeutic Target for Neuroendocrine Tumors.
Aristizabal Prada ET, Weis C, Orth M, Lauseker M, Spöttl G, Maurer J, Grabowski P, Grossman A, Auernhammer CJ, Nölting S. Aristizabal Prada ET, et al. Among authors: nolting s. Neuroendocrinology. 2018;106(4):335-351. doi: 10.1159/000481887. Epub 2017 Oct 2. Neuroendocrinology. 2018. PMID: 28968593 Free article.
Carcinoid and other tumors metastatic to the breast.
Kashlan RB, Powell RW, Nolting SF. Kashlan RB, et al. Among authors: nolting sf. J Surg Oncol. 1982 May;20(1):25-30. doi: 10.1002/jso.2930200107. J Surg Oncol. 1982. PMID: 7078182 No abstract available.
Combined inhibition of mTORC1 and mTORC2 signaling pathways is a promising therapeutic option in inhibiting pheochromocytoma tumor growth: in vitro and in vivo studies in female athymic nude mice.
Giubellino A, Bullova P, Nölting S, Turkova H, Powers JF, Liu Q, Guichard S, Tischler AS, Grossman AB, Pacak K. Giubellino A, et al. Among authors: nolting s. Endocrinology. 2013 Feb;154(2):646-55. doi: 10.1210/en.2012-1854. Epub 2013 Jan 10. Endocrinology. 2013. PMID: 23307788 Free PMC article.
Anti-cancer potential of MAPK pathway inhibition in paragangliomas-effect of different statins on mouse pheochromocytoma cells.
Fliedner SM, Engel T, Lendvai NK, Shankavaram U, Nölting S, Wesley R, Elkahloun AG, Ungefroren H, Oldoerp A, Lampert G, Lehnert H, Timmers H, Pacak K. Fliedner SM, et al. Among authors: nolting s. PLoS One. 2014 May 20;9(5):e97712. doi: 10.1371/journal.pone.0097712. eCollection 2014. PLoS One. 2014. PMID: 24846270 Free PMC article.
The role of GSK3 and its reversal with GSK3 antagonism in everolimus resistance.
Aristizabal Prada ET, Spöttl G, Maurer J, Lauseker M, Koziolek EJ, Schrader J, Grossman A, Pacak K, Beuschlein F, Auernhammer CJ, Nölting S. Aristizabal Prada ET, et al. Among authors: nolting s. Endocr Relat Cancer. 2018 Oct;25(10):893-908. doi: 10.1530/ERC-18-0159. Epub 2018 Jun 12. Endocr Relat Cancer. 2018. PMID: 29895527 Free PMC article.
152 results